References
- Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin‐dependent patients. N Engl J Med 1984; 311: 89–93
- Bennett P. H., Haffner S., Kasiske B. L., Keane W. F., Mogensen C. E., Parving H. H., Steffes M. W., Striker G. E. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25: 107–12
- Sacks D. B., Bruns D. E., Goldstein D. E., Maclaren N. K., McDonald J. M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436–72
- Deckert T., Feldt‐Rasmussen B., Borch‐Johnsen K., Jensen T., Kofoed‐Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 319–23
- Damsgaard E. M., Froland A., Jorgensen O. D., Mogensen C. E. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297–300
- Verhave J. C., Gansevoort R. T., Hillege H. L., Bakker S. J. L., de Zeeuw D., de Jong P. E. for the PREVEND Study Group. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int 2004; 66 Suppl 92: S18–21
- Levey A. S., Coresh J., Balk E., Kausz A. T., Levin A., Steffes M. W., et al. National Kidney Foundation Practice Guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–47
- Warnock D. G. Inclusion of albumin as a target in therapy guidelines: guidelines for chronic kidney disease. Kidney Int 2004; 66 Suppl 92: S121–3
- Kidney Disease: Improving Global Outcomes (KDIGO) project has a website www.kdigo.org Cited material is linked to Kidney Disease Outcomes: Quality Initiative (K/DOQI) website www.kdoqi.org: Part 5 Evaluation of laboratory measurements for clinical assessment of kidney disease (accessed 4.12.2007)
- Kouri T., Fogazzi G., Gant V., Hallander H., Hofmann W., Guder W. G. ECLM – European Urinalysis Guidelines. Scand J Clin Lab Invest 2000; 60 Suppl 231: 1–96
- Pugia M. J., Lott J. A., Clark L. W., Parker D. R., Wallace J. F., Willis T. W. Comparison of urine dipsticks with quantitative methods for microalbuminuria. Eur J Clin Chem Clin Biochem 1997; 35: 693–700
- Parsons M., Newman D. J., Pugia M., Newall R. G., Price C. P. Performance of a reagent strip device for quantitation of the urine albumin: creatinine ratio in a point of care setting. Clin Nephrol 1999; 51: 220–7
- Winkens R. A. G., Leffers P., Degenaar C. P., Houben A. W. The reproducibility of urinalysis using multiple reagent test strips. Eur J Clin Chem Clin Biochem 1991; 29: 813–18
- Kallner A., Estonius E. Are there advantages with U‐Albumin/U‐Creatinine ratios compared with U‐Albumin in monitoring diabetes?. Scand J Clin Lab Invest 2005; 65: 439–46
- Hofmann W., Guder W. G. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989; 27: 589–600
- Kouri T., Harmoinen A., Laurila K., Ala‐Houhala I., Koivula T., Pasternack A. Reference invervals for the markers of proteinuria with a standardized bed‐rest collection of urine. Clin Chem Lab Med 2001; 39: 418–25
- Comper W. D., Osicka T. M., Clark M., MacIsaac R. J., Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004; 65: 1850–5